Bhalchandra V. Joshi

2.4k total citations · 1 hit paper
46 papers, 2.0k citations indexed

About

Bhalchandra V. Joshi is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Bhalchandra V. Joshi has authored 46 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Physiology, 19 papers in Molecular Biology and 14 papers in Organic Chemistry. Recurrent topics in Bhalchandra V. Joshi's work include Adenosine and Purinergic Signaling (32 papers), Pharmacological Receptor Mechanisms and Effects (11 papers) and Receptor Mechanisms and Signaling (8 papers). Bhalchandra V. Joshi is often cited by papers focused on Adenosine and Purinergic Signaling (32 papers), Pharmacological Receptor Mechanisms and Effects (11 papers) and Receptor Mechanisms and Signaling (8 papers). Bhalchandra V. Joshi collaborates with scholars based in United States, United Kingdom and South Korea. Bhalchandra V. Joshi's co-authors include Kenneth A. Jacobson, Youichi Shinozaki, Keiko Ohsawa, Shinichi Kohsaka, Zhan‐Guo Gao, Schuichi Koizumi, Kazuhide Inoue, Makoto Tsuda, Yukari Shigemoto‐Mogami and Susanna Tchilibon and has published in prestigious journals such as Nature, Circulation Research and The FASEB Journal.

In The Last Decade

Bhalchandra V. Joshi

46 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis

2007 653 citations Schuichi Koizumi, Yukari Shigemoto‐Mogami et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bhalchandra V. Joshi United States	23	1.1k	788	463	435	282	46	2.0k
Edward Leung Italy	24	1.1k 1.0×	1.0k 1.3×	152 0.3×	364 0.8×	157 0.6×	52	2.2k
Edward Leung Italy	23	981 0.9×	874 1.1×	148 0.3×	293 0.7×	126 0.4×	36	1.8k
Tina C. Wan United States	22	832 0.8×	749 1.0×	141 0.3×	103 0.2×	170 0.6×	45	1.6k
Ali El‐Tayeb Germany	21	958 0.9×	506 0.6×	105 0.2×	234 0.5×	141 0.5×	29	1.3k
Joel R. Gever United States	20	573 0.5×	684 0.9×	161 0.3×	167 0.4×	39 0.1×	33	1.6k
Margot W. Beukers Netherlands	27	849 0.8×	1.0k 1.3×	61 0.1×	410 0.9×	54 0.2×	42	1.9k
J.M. Boeynaems Belgium	26	859 0.8×	882 1.1×	86 0.2×	63 0.1×	234 0.8×	55	2.1k
Noel J. Cusack United Kingdom	29	1.3k 1.2×	833 1.1×	46 0.1×	238 0.5×	94 0.3×	61	2.2k
Ralf Hausmann Germany	22	774 0.7×	535 0.7×	51 0.1×	117 0.3×	78 0.3×	49	1.4k
Jorge Gonçalves Portugal	22	362 0.3×	758 1.0×	134 0.3×	42 0.1×	57 0.2×	65	1.4k

Countries citing papers authored by Bhalchandra V. Joshi

Since Specialization

Citations

This map shows the geographic impact of Bhalchandra V. Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhalchandra V. Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhalchandra V. Joshi more than expected).

Fields of papers citing papers by Bhalchandra V. Joshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhalchandra V. Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhalchandra V. Joshi. The network helps show where Bhalchandra V. Joshi may publish in the future.

Co-authorship network of co-authors of Bhalchandra V. Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Bhalchandra V. Joshi. A scholar is included among the top collaborators of Bhalchandra V. Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhalchandra V. Joshi. Bhalchandra V. Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Zhao, Chi Wai, Marcel Y. Ávila, et al.. (2009). Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species. Experimental Eye Research. 90(1). 146–154. 34 indexed citations

Calenbergh, Serge Van, Bhalchandra V. Joshi, Hyojin Ko, et al.. (2009). Synthesis and P2Y receptor activity of nucleoside 5′-phosphonate derivatives. Bioorganic & Medicinal Chemistry Letters. 19(11). 3002–3005. 18 indexed citations

Ko, Hyojin, Arijit Das, Rhonda L. Carter, et al.. (2009). Molecular recognition in the P2Y14 receptor: Probing the structurally permissive terminal sugar moiety of uridine-5′-diphosphoglucose. Bioorganic & Medicinal Chemistry. 17(14). 5298–5311. 32 indexed citations

Ochaion, Avivit, S. Bar‐Yehuda, Shira Cohen, et al.. (2008). The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-κB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats. Biochemical Pharmacology. 76(4). 482–494. 60 indexed citations

Gao, Zhan‐Guo, et al.. (2008). Synthesis and pharmacological characterization of [125I]MRS1898, a high-affinity, selective radioligand for the rat A3 adenosine receptor. Purinergic Signalling. 5(1). 31–37. 10 indexed citations

Lee, Ga Eun, Bhalchandra V. Joshi, Lak Shin Jeong, et al.. (2007). Synthesis and structure–activity relationship studies of tyrosine-based antagonists at the human P2X7 receptor. Bioorganic & Medicinal Chemistry Letters. 18(2). 571–575. 18 indexed citations

Koizumi, Schuichi, Yukari Shigemoto‐Mogami, Youichi Shinozaki, et al.. (2007). UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature. 446(7139). 1091–1095. 653 indexed citations breakdown →

Jacobson, Kenneth A., Stefano Costanzi, Bhalchandra V. Joshi, et al.. (2006). Agonists and Antagonists for P2 Receptors. Novartis Foundation symposium. 276. 58–72. 44 indexed citations

Shen, Jianbing, Chunxia Cronin, Д. Л. Сонин, et al.. (2006). P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 292(2). H1077–H1084. 29 indexed citations

10.

Matot, Idit, Carolyn F. Weiniger, Evelyne Zeira, et al.. (2006). A3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion. Critical Care. 10(2). R65–R65. 50 indexed citations

11.

Besada, Pedro, Liaman K. Mamedova, Krishnan K. Palaniappan, et al.. (2006). Nucleoside Prodrugs of A3 Adenosine Receptor Agonists and Antagonists. Collection of Czechoslovak Chemical Communications. 71(6). 912–928. 5 indexed citations

12.

Jacobson, Kenneth A., Stefano Costanzi, Soo‐Kyung Kim, et al.. (2006). Action of Nucleosides and Nucleotides at 7 Transmembrane-Spanning Receptors. Nucleosides Nucleotides & Nucleic Acids. 25(12). 1425–1436. 7 indexed citations

13.

Joshi, Bhalchandra V. & Kenneth A. Jacobson. (2005). Purine Derivatives as Ligands for A3 Adenosine Receptors. Current Topics in Medicinal Chemistry. 5(13). 1275–1295. 18 indexed citations

14.

Jacobson, Kenneth A., Liaman Mamedova, Bhalchandra V. Joshi, Pedro Besada, & Stefano Costanzi. (2005). Molecular Recognition at Adenine Nucleotide (P2) Receptors in Platelets. Seminars in Thrombosis and Hemostasis. 31(2). 205–216. 12 indexed citations

15.

Gao, Zhan‐Guo, Bhalchandra V. Joshi, Athena M. Klutz, et al.. (2005). Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5′-ribofuran-uronamide moiety. Bioorganic & Medicinal Chemistry Letters. 16(3). 596–601. 30 indexed citations

16.

Jacobson, Kenneth A., Stefano Costanzi, M. Ohno, et al.. (2004). Molecular Recognition at Purine and Pyrimidine Nucleotide (P2) Receptors. Current Topics in Medicinal Chemistry. 4(8). 805–819. 46 indexed citations

17.

Mamedova, Liaman K., Bhalchandra V. Joshi, Zhan‐Guo Gao, Ivar von Kügelgen, & Kenneth A. Jacobson. (2004). Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors. Biochemical Pharmacology. 67(9). 1763–1770. 135 indexed citations

18.

Cattaneo, Marco, Anna Lecchi, M. Ohno, et al.. (2004). Antiaggregatory activity in human platelets of potent antagonists of the P2Y1 receptor. Biochemical Pharmacology. 68(10). 1995–2002. 82 indexed citations

19.

Jacobson, Kenneth A., Susanna Tchilibon, Bhalchandra V. Joshi, & Zhan‐Guo Gao. (2003). Chapter 13. A3 adenosine receptors. PubMed. 38. 121–130. 6 indexed citations

20.

Joshi, Bhalchandra V. & Colin B. Reese. (1993). Ozonolysis of 6-N-benzoyl-9-(5-deoxy-2,3-O-isopropylidene-β-D-erythro-pent-4-enofuranosyl)adenine and related compounds. Tetrahedron Letters. 34(36). 5807–5810. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact